Читать книгу Sarcopenia - Группа авторов - Страница 75

Functional decline, or mobility limitations, initially classified as one of the adverse consequences, has been incorporated into the definition and diagnosis of sarcopenia. For example, a prospective study of Hong Kong Chinese older people proposed that sarcopenia may be defined in terms of risk of physical limitations [10] and other adverse outcomes [11], and anthropometric cut points based on incident mobility and physical limitation have been proposed [12]. Similarly, the Foundation of National Institute of Health (FNIH) also proposed a data‐driven approach in deriving cut points that is associated with slow walking speed (<0.8 m/s) [13]. Other consensus panel definitions used a combination of muscle mass, muscle strength, and physical performance measures in the diagnosis of sarcopenia [14, 15]. Systematic reviews show that sarcopenia is associated with increased odds ratio of functional decline between 2.5 and 3.0 [1, 3].